期刊
PHARMACEUTICS
卷 15, 期 11, 页码 -出版社
MDPI
DOI: 10.3390/pharmaceutics15112579
关键词
neonates; PBPK modeling; pharmacokinetics; ontogeny
Physiologically based pharmacokinetic (PBPK) modeling is a useful approach for predicting drug pharmacokinetics, especially in under-studied populations like pediatrics. However, there are important knowledge gaps for neonatal PBPK models, resulting in uncertainty in the predictions.
Physiologically based pharmacokinetic (PBPK) modeling is an approach to predicting drug pharmacokinetics, using knowledge of the human physiology involved and drug physiochemical properties. This approach is useful when predicting drug pharmacokinetics in under-studied populations, such as pediatrics. PBPK modeling is a particularly important tool for dose optimization for the neonatal population, given that clinical trials rarely include this patient population. However, important knowledge gaps exist for neonates, resulting in uncertainty with the model predictions. This review aims to outline the sources of variability that should be considered with developing a neonatal PBPK model, the data that are currently available for the neonatal ontogeny, and lastly to highlight the data gaps where further research would be needed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据